Vermont Qualifying Conditions: Detailed Guide
What conditions qualify for medical marijuana in Vermont?
Vermont approves medical marijuana for 13+ qualifying conditions including chronic pain, PTSD, cancer, epilepsy, and any chronic debilitating condition a physician approves. Even with recreational marijuana legal in Vermont, medical patients receive significant benefits including tax savings and higher cultivation limits. MMJ.com offers telehealth evaluations for $149.99 with same-day certification.## What is the complete list of Vermont qualifying conditions?
The Vermont Medical Marijuana Program (VMMP), managed by the Vermont Cannabis Control Board (CCB), recognizes the following qualifying conditions for 2026:
Pain Conditions
- Severe Chronic Pain (persistent pain unresponsive to standard treatments)
- Intractable Muscle Spasms
Neurological Conditions
- Seizure Disorders (including Epilepsy)
- Multiple Sclerosis (MS)
- Parkinson's Disease
Mental Health Conditions
- Post-Traumatic Stress Disorder (PTSD)
Cancer and Terminal Illness
- Cancer (pain, nausea, appetite loss)
- Terminal Illness (prognosis less than 12 months)
- Cachexia/Wasting Syndrome
Gastrointestinal Conditions
Infectious Diseases
- HIV/AIDS
Eye Conditions
Physician Discretion
Any other chronic, debilitating condition causing severe, persistent symptoms that a healthcare provider believes would benefit from medical cannabis.
About the Qualifying Medical Conditions
Below is information about each qualifying condition and the research that informed Vermont's decision to include it in the state program.
Severe Chronic Pain
Severe chronic pain is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on systematic reviews examining cannabinoid use among patients with chronic pain conditions.
PTSD
PTSD is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on research examining cannabinoid use among patients with PTSD.
Epilepsy and Seizure Disorders
Seizure disorders, including epilepsy, are approved qualifying conditions under Vermont's medical marijuana program. Vermont included these conditions based on clinical trial research examining CBD in patients with treatment-resistant epilepsy.
Cancer and Chemotherapy Side Effects
Cancer is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on research examining cannabinoid use among cancer patients experiencing treatment-related symptoms.
Multiple Sclerosis
MS is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on clinical research examining cannabinoid use in patients with MS-related spasticity.
Parkinson's Disease
Parkinson's Disease is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on research examining cannabinoid use among Parkinson's patients.
Crohn's Disease
Crohn's Disease is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on clinical research examining cannabis use in IBD patients.
HIV/AIDS
HIV/AIDS is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on research examining cannabinoid use among HIV/AIDS patients.
Glaucoma
Glaucoma is an approved qualifying condition under Vermont's medical marijuana program. Vermont included this condition based on early research examining the relationship between cannabinoids and intraocular pressure.
Physician Discretion Conditions
Vermont's physician discretion clause allows healthcare providers to recommend medical marijuana for any chronic, debilitating condition they believe would benefit. This is based on Vermont statute and does not require specific research citations for each condition.
Medical Disclaimer
This page provides information about Vermont's qualifying conditions for medical cannabis. The inclusion of a condition in Vermont's program does not constitute medical advice or a guarantee of therapeutic benefit. Individual results vary. Potential side effects may include dizziness, sedation, and cognitive changes. Always consult a healthcare provider before starting treatment.
Reviewed by MMJ.com Medical Advisory Team Last Updated: December 17, 2025